Composition, form of production and packaging
? Tablets are round, flat, with even edges, beige-brown in color, it is allowed the presence of inclusions and heterogeneity of color in the form of "marble", with dividing risk on one side; diameter of 25 mm.
1 tab.
substance 1.575 g,
containing dried viable cells of Lactobacillus delbrueckii spp. bulgaricus strain 51 (LB-51) not less than 1 Г— 10 2 cells,
and:
protein from 25 to 35%,
which in terms of total nitrogen is from 4 to 5.6%
lactic acid from 6.3 to 12.6%
Excipients: sucrose (not more than 900 mg), magnesium stearate.
6 pcs. - blisters (1) - packs of cardboard.
6 pcs. - blisters (3) - packs of cardboard.
INSTRUCTION FOR THE SPECIALIST.
The product description was approved by the manufacturer for the 2009 print edition.
PHARMACHOLOGIC EFFECT
A drug that exerts a protective effect on the mucous membrane of the stomach and intestines.
The effect of the drug is provided by the presence of Lactobacillus bulgaris and biologically active products of their vital activity (lactic and malic acid, nucleic acids, a number of alpha-amino acids, polypeptides and polysaccharides), as well as high protein content (25-30%), which have a protective effect on the mucosa GIT, stimulating regeneration processes in the mucous membrane of the stomach and duodenum. The drug also has analgesic and antacid effects due to the buffer properties of the protein that is part of the drug.
PHARMACOKINETICS
Data on the pharmacokinetics of the drug Gastrofarm are not available.
INDICATIONS
- Acute and chronic gastritis, accompanied by high acidity of gastric juice;
- Stomach ulcer and duodenal ulcer;
- as a prophylactic agent during and after treatment with drugs that have an irritant effect on the digestive tract;
- as a preventive remedy after the errors in the diet (intake of food, which causes an increase in the acidity of the gastric juice) and excessive consumption of alcohol and smoking.
DOSING MODE
Tablets are taken orally 30 minutes before meals, chewing with a small amount of water or pre-crushed and mixed with a small amount of boiled water at room temperature.
In acute and chronic gastritis and with increased acidity of gastric juice, adults are prescribed 1-2 tablets. 3 times / day; children aged 3 to 12 years - 1/2 tab., at theage of 12 to 18 years - 1 tab. 3 times / day. The course of treatment is 30 days.
With acute gastritis and insufficient effectiveness of therapy, the daily dose can be increased 2 times.
The effect is usually observed by the end of the first week of treatment.
With peptic ulcer of the stomach and duodenum, adults are prescribed 3-4 tablets each. 3 times / day for 30 days.
For prophylaxis the drug is used in a dose of 1 to 2 tab. 3 times / day for 15 days, with alcohol or smoking abuse - 1-2 tablespoons. 2-3 times / day.
SIDE EFFECT
When applying the drug according to the indications in the recommended doses, the side effect was not revealed.
CONTRAINDICATIONS
When used according to indications and in recommended doses are not established.
PREGNANCY AND LACTATION
Data on the use of the drug during pregnancy and lactation (breastfeeding) is not provided.
APPLICATION FOR CHILDREN
The drug is prescribed for children over 3 years of age (see Dosage regimen).
SPECIAL INSTRUCTIONS
The drug is harmless, non-toxic.
When prescribing a patient with diabetes, it should be borne in mind that in 1 tab. contains 0.9 g of sucrose.
Impact on the ability to drive vehicles and manage mechanisms
The drug does not affect the ability to drive vehicles.
OVERDOSE
Currently, cases of overdose of Gastropharm is not described.
DRUG INTERACTION
Drug interaction of the drug Gastrofarm is not established and the drug can be used with other medicines.
TERMS OF RELEASE FROM PHARMACY
The drug is approved for use as a means of OTC.
TERMS AND CONDITIONS OF STORAGE
The drug should be stored in a dry, protected from light, out of reach of children at a temperature of no higher than 25 В° C. Shelf life - 2 years.
